- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pancreatic Neuroendocrine Tumor G2 in New Zealand
Total 926 results
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent MelanomaUnited States
-
ActelionCompleted
-
Melanoma Institute AustraliaActive, not recruiting
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more
-
Novartis PharmaceuticalsCompletedCarcinoid Tumor | Malignant Carcinoid SyndromeFrance, Spain, Netherlands, United States, Canada, Sweden, Italy, Australia, Germany, Greece, Belgium, Czech Republic, Slovakia, Finland, United Kingdom
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; NYU Langone HealthCompletedSkin Cancer | Metastatic Melanoma | NeoplasmUnited States
-
Rockefeller UniversityCompletedMelanoma | Neoplasm MetastasisUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
Cascadian Therapeutics Inc.TerminatedAdvanced BRAF-mutant CancersUnited States
-
StemcentrxTerminatedSmall Cell Lung CancerUnited States
-
National Cancer Institute (NCI)WithdrawnStage IV Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedBRAF Positive Metastatic MelanomaUnited States
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
Roswell Park Cancer InstituteBayerCompletedUnspecified Adult Solid Tumor, Protocol Specific | Acinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
Idera Pharmaceuticals, Inc.CompletedMelanoma | Refractory Solid TumorsUnited States, Israel
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
TakedaCompletedMelanoma | NeoplasmsUnited States, Australia
-
Genta IncorporatedCompletedDacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant MelanomaMelanoma (Skin)United States
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
White Plains HospitalRecruitingPancreatic Cancer | Pancreatic Adenocarcinoma | Lynch Syndrome | Pancreas Cancer | HNPCC | Familial Pancreatic Cancer | Hereditary Pancreatitis | BRCA 1/2 | FAMMM | Familial Atypical Multiple Mole Melanoma | Peutz Jeghers SyndromeUnited States
-
GlaxoSmithKlineUnknownMelanoma (Skin)United States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedGastric Cancer | Colorectal Cancer | Small Intestine Cancer | Ovarian Cancer | Peritoneal Cavity Cancer | Gastrointestinal Stromal Tumor | Gastrointestinal Carcinoid TumorUnited States
-
AmgenCompletedSarcoma | Lymphoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumors | Metastatic Cancer | Solid Tumors | Carcinoid | Locally AdvancedUnited States, Spain, Poland
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Molecular Insight Pharmaceuticals, Inc.UnknownPheochromocytoma | ParagangliomaUnited States
-
Genentech, Inc.Terminated
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingStage III/IV MelanomaUnited States, Australia, Canada, Italy, Switzerland
-
Ruhr University of BochumCompleted
-
PfizerCompleted
-
Hummingbird BioscienceRecruitingPancreatic Cancer | Non-Small Cell Lung Cancer | Metastatic Solid Tumor | Locally Advanced Solid TumorAustralia
-
GlaxoSmithKlineCompletedMelanomaUnited States, Italy, United Kingdom, France, Sweden, Germany, Poland, Australia, Belgium, Austria, Canada, Czechia, Greece, Russian Federation, Ukraine, Norway, Switzerland, New Zealand, Argentina
-
Provectus PharmaceuticalsCompleted
-
SkylineDxRecruitingMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Melanoma Stage IIIUnited States
-
GlaxoSmithKlineCompleted
-
Karyopharm Therapeutics IncActive, not recruitingLocally Advanced Unresectable or Metastatic MelanomaUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Hoffmann-La RocheRecruitingSmall Cell Lung Cancer | Neuroendocrine CarcinomaUnited States, Japan, Denmark, Spain, Poland
-
Synta Pharmaceuticals Corp.TerminatedMelanomaUnited States, Spain, Canada, Australia, Germany, Puerto Rico, Romania, United Kingdom
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Bristol-Myers SquibbMedarexCompletedAdvanced MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedUveal MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Suthee RapisuwonBristol-Myers SquibbActive, not recruitingMelanoma | Ocular MelanomaUnited States
-
Evaxion Biotech A/SMerck Sharp & Dohme LLCRecruitingMelanoma Stage IV | Melanoma Stage IIIAustralia